Your SlideShare is downloading. ×
0
Amap Overview 2010
Amap Overview 2010
Amap Overview 2010
Amap Overview 2010
Amap Overview 2010
Amap Overview 2010
Amap Overview 2010
Amap Overview 2010
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Amap Overview 2010

121

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
121
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  1. Association of Medical Affairs Professionals Overview
  2. Ver. SK062510CP Organization • Non-profit organization supporting Medical Affairs professionals in Pharmaceutical, Biotechnology and Medical Device Companies
  3. Ver. SK062510CP Mission Sharing of best practices • Advocacy: – Set a stage for appropriate medical communications between medical professionals within pharmaceutical companies and physicians 3
  4. Ver. SK062510CP Mission Sharing of best practices • Provide a platform for education and professional development for the membership – Create and establish understanding of what medical affairs function is all about 4
  5. Ver. SK062510CP Mission Sharing of best practices • Self interest and higher interest – Self interest: training, articles, journals, best practice sharing, networking – Higher interest: scientific communication, ensuring that physicians understand the role of medical affairs, looking for innovative ways of doing studies 5
  6. Ver. SK062510CP Management • Operating Board of Directors – Elected – two year term – Each board seat focused on specific areas of the organization – Chairperson • Elected – two year term • Executive Board – Invited – Two year Term 6
  7. Ver. SK062510CP Current Status • Filing for 501(c)3 non profit status • Expanded enrollment to begin late 2010 • Started Process of Setting up European Executive Board ©2010 Skila, a Sela2 Company. All Rights Reserved. Proprietary and Confidential. 7
  8. Ver. SK062510CP Executive Committee ©2010 Skila, a Sela2 Company. All Rights Reserved. Proprietary and Confidential. 8 Simon Mason Skila Dr. Steven James Allergan Kathy Presto Roche Dr. Ken Newman Medical Affairs Consultant – former Boehringer Ingelheim/Forest Shahin Gharakhanian Vertex Pharma Dr. Charles Hugh-Jones Sanofi-Aventis Dr. William Sigmund GSK Dr. Paul Weber PTC Biotech

×